RP2

· Replimune, Inc.

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for RP2, covering 2025-10-20 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Study of RP2 as Immunoprevention in High-Risk Oral Precancerous Disease [Phase 2]